Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients

NCT01353963 · clinicaltrials.gov ↗

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder
Vasomotor Symptoms

Interventions

DRUG: desvenlafaxine succinate

Sponsor

Pfizer